Abstract Cannabinoids inhibit motility and secretion in the intestine. They are now assigned the additional task of curbing excessive inflammation, suggesting that drugs targeting the endogenous cannabinoid system could be exploited for inflammatory bowel disease....
![New Study: Crohn’s Disease Mitigated By Cannabis]()
The federal government steadfastly refuses to acknowledge the therapeutic utility of the cannabis plant, stating as recently as this past July that it possesses: “a high potential for abuse; … no currently accepted medical use in treatment in the United States; …...
Rochester, MN: The administration of synthetic THC (aka dronabinol) decreases colonic motility compared to placebo in patients with irritable bowel syndrome (IBS), according to clinical trial data to be published in the journal Gastroenterology. Investigators at the...
The use of cannabis is common among patients with inflammatory bowel disease (IBD), according to survey data to be published in the European Journal of Gastroenterology and Hepatology. An international team of researchers from Mount Sinai Hospital in Toronto and the...
